UPDATE: Amarin (AMRN) Surges; Is It NCE Related?
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
FDA Says NCE Status on Amarin (AMRN) Has Not Yet Been Determined
October 18, 2012 1:07 PM EDTAmarin Corporation plc (NASDAQ: AMRN) is giving back some earlier gains after the FDA said NCE status has not yet been determined.
As noted earlier, shares were ramping on heavy volume earlier on... More
